A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.

Launched by NOVOBLISS RESEARCH PVT LTD · Jul 31, 2025

Keywords

ClinConnect Summary

This clinical study is testing a new skin product called Pinorox® to see if it is safe and effective for reducing visible signs of aging on the face, such as wrinkles, fine lines, and dark spots. The study will carefully compare results from different groups to understand how well Pinorox® works and whether participants tolerate it well without unwanted side effects.

Adults between 35 and 55 years old who have wrinkles or dark spots around their eyes (often called “crow’s feet”) and on their face may be eligible to join. Both men and women can participate, but women who could become pregnant need to confirm they are not pregnant before starting. Participants should not have used other skin-aging treatments for at least three months before the study and must agree to follow the study instructions, including using the product as directed, attending all visits, and keeping a daily diary of product use and any medications taken. People with certain skin conditions, allergies, or who are pregnant or breastfeeding cannot join. The study is not yet open for recruiting, but once it begins, participants can expect to be closely monitored to see how their skin responds to Pinorox®.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) Age: 35 to 55 years (both inclusive) at the time of consent. 2) Sex: Adult male and female having Crow's feet area wrinkles, fine lines, facial dark spots.
• • 3) Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit.
• • 4) Subjects should not have used any cosmetic, nutraceutical or therapeutic products for skin ageing in last 3 months.
• • 5) Subjects are not allowed to participate in any other study until this study is complete.
• • 6) Subjects must be willing and able to follow the study directions and to return for all specified visits with the product.
• • 7) Subjects must agree to record each use of the test products in the subject's diary card on daily basis.
• • 8) Subjects must agree to record medication use during the study
• Exclusion Criteria:
• • 1) Subjects who are on steroids for last six months. 2) Subjects who have used any cosmetic, nutraceutical or therapeutic products for skin last three months.
• • 3) Subjects who are on product which contains kojic acid, glycolic acid, niacinamide, alpha arbutin, Vitamin C and other skin ageing product.
• • 4) Subjects with other dermatologic diseases whose presence or treatments could interfere with the assessment of study.
• • 5) Subjects that are pregnant and/or breastfeeding. 6) The subject has a known allergy or sensitivity to soaps, lotions, detergents, detanglers or fragrances.
• • 7) Subjects if do not agree to limit sun exposure to affected areas such as face during prolonged sun exposure.
• • 8) The subject has any other skin conditions i.e. cuts, scratches, ring worms, etc. which in the opinion of the Investigator, will interfere with the study results or will create undue risk for the subject.
• • 9) The subject has any of the conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results.
• • 10) The subject is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data.
• • 11) Any other condition which could warrant exclusion from the study, as per the dermatologist's/investigator's discretion.